CN111500652B - 一种制备氟苯尼考的方法 - Google Patents
一种制备氟苯尼考的方法 Download PDFInfo
- Publication number
- CN111500652B CN111500652B CN201910387166.6A CN201910387166A CN111500652B CN 111500652 B CN111500652 B CN 111500652B CN 201910387166 A CN201910387166 A CN 201910387166A CN 111500652 B CN111500652 B CN 111500652B
- Authority
- CN
- China
- Prior art keywords
- gly
- reaction
- ala
- val
- thr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229960003760 florfenicol Drugs 0.000 title claims abstract description 36
- AYIRNRDRBQJXIF-NXEZZACHSA-N (-)-Florfenicol Chemical compound CS(=O)(=O)C1=CC=C([C@@H](O)[C@@H](CF)NC(=O)C(Cl)Cl)C=C1 AYIRNRDRBQJXIF-NXEZZACHSA-N 0.000 title claims abstract description 32
- 238000000034 method Methods 0.000 title claims abstract description 22
- 101001110310 Lentilactobacillus kefiri NADP-dependent (R)-specific alcohol dehydrogenase Proteins 0.000 claims abstract description 16
- 150000001875 compounds Chemical class 0.000 claims abstract description 14
- 238000007142 ring opening reaction Methods 0.000 claims abstract description 9
- 238000003682 fluorination reaction Methods 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 238000010511 deprotection reaction Methods 0.000 claims abstract description 4
- 238000006640 acetylation reaction Methods 0.000 claims abstract description 3
- 125000003963 dichloro group Chemical group Cl* 0.000 claims abstract description 3
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 claims description 12
- 229950006238 nadide Drugs 0.000 claims description 12
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 claims description 12
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 239000005515 coenzyme Substances 0.000 claims description 6
- 230000008929 regeneration Effects 0.000 claims description 6
- 238000011069 regeneration method Methods 0.000 claims description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 5
- 108010050375 Glucose 1-Dehydrogenase Proteins 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- NTJBWZHVSJNKAD-UHFFFAOYSA-N triethylazanium;fluoride Chemical compound [F-].CC[NH+](CC)CC NTJBWZHVSJNKAD-UHFFFAOYSA-N 0.000 claims description 5
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 3
- 102000007698 Alcohol dehydrogenase Human genes 0.000 claims description 2
- 108010021809 Alcohol dehydrogenase Proteins 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 238000006911 enzymatic reaction Methods 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 description 61
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 36
- -1 amino acid copper salt Chemical class 0.000 description 23
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 18
- 239000000047 product Substances 0.000 description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 239000012043 crude product Substances 0.000 description 15
- 230000015572 biosynthetic process Effects 0.000 description 14
- 238000003786 synthesis reaction Methods 0.000 description 14
- 238000003756 stirring Methods 0.000 description 11
- 239000012074 organic phase Substances 0.000 description 10
- 108090000790 Enzymes Proteins 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 238000004128 high performance liquid chromatography Methods 0.000 description 9
- 239000010410 layer Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 239000000706 filtrate Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 238000001914 filtration Methods 0.000 description 7
- 239000012044 organic layer Substances 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 108010079364 N-glycylalanine Proteins 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- 108010050848 glycylleucine Proteins 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- WKOBSJOZRJJVRZ-FXQIFTODSA-N Ala-Glu-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O WKOBSJOZRJJVRZ-FXQIFTODSA-N 0.000 description 3
- FBHOPGDGELNWRH-DRZSPHRISA-N Ala-Glu-Phe Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O FBHOPGDGELNWRH-DRZSPHRISA-N 0.000 description 3
- SIGTYDNEPYEXGK-ZANVPECISA-N Ala-Gly-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)CNC(=O)[C@@H](N)C)C(O)=O)=CNC2=C1 SIGTYDNEPYEXGK-ZANVPECISA-N 0.000 description 3
- LNNSWWRRYJLGNI-NAKRPEOUSA-N Ala-Ile-Val Chemical compound C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(O)=O LNNSWWRRYJLGNI-NAKRPEOUSA-N 0.000 description 3
- RMAWDDRDTRSZIR-ZLUOBGJFSA-N Ala-Ser-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O RMAWDDRDTRSZIR-ZLUOBGJFSA-N 0.000 description 3
- SLNCSSWAIDUUGF-LSJOCFKGSA-N Arg-His-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(O)=O SLNCSSWAIDUUGF-LSJOCFKGSA-N 0.000 description 3
- OKKMBOSPBDASEP-CYDGBPFRSA-N Arg-Ile-Met Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(O)=O OKKMBOSPBDASEP-CYDGBPFRSA-N 0.000 description 3
- UZGFHWIJWPUPOH-IHRRRGAJSA-N Arg-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N UZGFHWIJWPUPOH-IHRRRGAJSA-N 0.000 description 3
- SLQQPJBDBVPVQV-JYJNAYRXSA-N Arg-Phe-Val Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(O)=O SLQQPJBDBVPVQV-JYJNAYRXSA-N 0.000 description 3
- DDBMKOCQWNFDBH-RHYQMDGZSA-N Arg-Thr-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)O DDBMKOCQWNFDBH-RHYQMDGZSA-N 0.000 description 3
- HZPSDHRYYIORKR-WHFBIAKZSA-N Asn-Ala-Gly Chemical compound OC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CC(N)=O HZPSDHRYYIORKR-WHFBIAKZSA-N 0.000 description 3
- XWGJDUSDTRPQRK-ZLUOBGJFSA-N Asn-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(N)=O XWGJDUSDTRPQRK-ZLUOBGJFSA-N 0.000 description 3
- ZWASIOHRQWRWAS-UGYAYLCHSA-N Asn-Asp-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O ZWASIOHRQWRWAS-UGYAYLCHSA-N 0.000 description 3
- WSGVTKZFVJSJOG-RCOVLWMOSA-N Asp-Gly-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O WSGVTKZFVJSJOG-RCOVLWMOSA-N 0.000 description 3
- GFYOIYJJMSHLSN-QXEWZRGKSA-N Asp-Val-Arg Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O GFYOIYJJMSHLSN-QXEWZRGKSA-N 0.000 description 3
- XWKPSMRPIKKDDU-RCOVLWMOSA-N Asp-Val-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O XWKPSMRPIKKDDU-RCOVLWMOSA-N 0.000 description 3
- UXRVDHVARNBOIO-QSFUFRPTSA-N Asp-Val-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)O)N UXRVDHVARNBOIO-QSFUFRPTSA-N 0.000 description 3
- NYDNBYSDYGXNFH-UHFFFAOYSA-N CS(=O)(=O)c1ccc(cc1)C(=O)C1CN1 Chemical compound CS(=O)(=O)c1ccc(cc1)C(=O)C1CN1 NYDNBYSDYGXNFH-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- LTXLIIZACMCQTO-GUBZILKMSA-N Gln-His-Asp Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)N)N LTXLIIZACMCQTO-GUBZILKMSA-N 0.000 description 3
- SBCYJMOOHUDWDA-NUMRIWBASA-N Glu-Asp-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SBCYJMOOHUDWDA-NUMRIWBASA-N 0.000 description 3
- SJPMNHCEWPTRBR-BQBZGAKWSA-N Glu-Glu-Gly Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O SJPMNHCEWPTRBR-BQBZGAKWSA-N 0.000 description 3
- ZWQVYZXPYSYPJD-RYUDHWBXSA-N Glu-Gly-Phe Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 ZWQVYZXPYSYPJD-RYUDHWBXSA-N 0.000 description 3
- OQXDUSZKISQQSS-GUBZILKMSA-N Glu-Lys-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O OQXDUSZKISQQSS-GUBZILKMSA-N 0.000 description 3
- QOXDAWODGSIDDI-GUBZILKMSA-N Glu-Ser-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)N QOXDAWODGSIDDI-GUBZILKMSA-N 0.000 description 3
- JDAYMLXPUJRSDJ-XIRDDKMYSA-N Glu-Trp-Arg Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCC(O)=O)N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)=CNC2=C1 JDAYMLXPUJRSDJ-XIRDDKMYSA-N 0.000 description 3
- 108010035289 Glucose Dehydrogenases Proteins 0.000 description 3
- LJPIRKICOISLKN-WHFBIAKZSA-N Gly-Ala-Ser Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O LJPIRKICOISLKN-WHFBIAKZSA-N 0.000 description 3
- QIZJOTQTCAGKPU-KWQFWETISA-N Gly-Ala-Tyr Chemical compound [NH3+]CC(=O)N[C@@H](C)C(=O)N[C@H](C([O-])=O)CC1=CC=C(O)C=C1 QIZJOTQTCAGKPU-KWQFWETISA-N 0.000 description 3
- JRDYDYXZKFNNRQ-XPUUQOCRSA-N Gly-Ala-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)CN JRDYDYXZKFNNRQ-XPUUQOCRSA-N 0.000 description 3
- UQJNXZSSGQIPIQ-FBCQKBJTSA-N Gly-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)CN UQJNXZSSGQIPIQ-FBCQKBJTSA-N 0.000 description 3
- HHSOPSCKAZKQHQ-PEXQALLHSA-N Gly-His-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)CN HHSOPSCKAZKQHQ-PEXQALLHSA-N 0.000 description 3
- SWQALSGKVLYKDT-UHFFFAOYSA-N Gly-Ile-Ala Natural products NCC(=O)NC(C(C)CC)C(=O)NC(C)C(O)=O SWQALSGKVLYKDT-UHFFFAOYSA-N 0.000 description 3
- VIIBEIQMLJEUJG-LAEOZQHASA-N Gly-Ile-Gln Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(O)=O VIIBEIQMLJEUJG-LAEOZQHASA-N 0.000 description 3
- PAWIVEIWWYGBAM-YUMQZZPRSA-N Gly-Leu-Ala Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O PAWIVEIWWYGBAM-YUMQZZPRSA-N 0.000 description 3
- OQQKUTVULYLCDG-ONGXEEELSA-N Gly-Lys-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CN)C(O)=O OQQKUTVULYLCDG-ONGXEEELSA-N 0.000 description 3
- KOYUSMBPJOVSOO-XEGUGMAKSA-N Gly-Tyr-Ile Chemical compound [H]NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O KOYUSMBPJOVSOO-XEGUGMAKSA-N 0.000 description 3
- GBYYQVBXFVDJPJ-WLTAIBSBSA-N Gly-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)CN)O GBYYQVBXFVDJPJ-WLTAIBSBSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- VSZALHITQINTGC-GHCJXIJMSA-N Ile-Ala-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O)N VSZALHITQINTGC-GHCJXIJMSA-N 0.000 description 3
- MKWSZEHGHSLNPF-NAKRPEOUSA-N Ile-Ala-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)O)N MKWSZEHGHSLNPF-NAKRPEOUSA-N 0.000 description 3
- SVBAHOMTJRFSIC-SXTJYALSSA-N Ile-Ile-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)N)C(=O)O)N SVBAHOMTJRFSIC-SXTJYALSSA-N 0.000 description 3
- YBKKLDBBPFIXBQ-MBLNEYKQSA-N Ile-Thr-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)O)N YBKKLDBBPFIXBQ-MBLNEYKQSA-N 0.000 description 3
- KFKWRHQBZQICHA-STQMWFEESA-N L-leucyl-L-phenylalanine Natural products CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 KFKWRHQBZQICHA-STQMWFEESA-N 0.000 description 3
- FGNQZXKVAZIMCI-CIUDSAMLSA-N Leu-Asp-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)O)N FGNQZXKVAZIMCI-CIUDSAMLSA-N 0.000 description 3
- NEEOBPIXKWSBRF-IUCAKERBSA-N Leu-Glu-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O NEEOBPIXKWSBRF-IUCAKERBSA-N 0.000 description 3
- CCQLQKZTXZBXTN-NHCYSSNCSA-N Leu-Gly-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(O)=O CCQLQKZTXZBXTN-NHCYSSNCSA-N 0.000 description 3
- NTBFKPBULZGXQL-KKUMJFAQSA-N Lys-Asp-Tyr Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 NTBFKPBULZGXQL-KKUMJFAQSA-N 0.000 description 3
- GQFDWEDHOQRNLC-QWRGUYRKSA-N Lys-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN GQFDWEDHOQRNLC-QWRGUYRKSA-N 0.000 description 3
- AIRZWUMAHCDDHR-KKUMJFAQSA-N Lys-Leu-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O AIRZWUMAHCDDHR-KKUMJFAQSA-N 0.000 description 3
- WLXGMVVHTIUPHE-ULQDDVLXSA-N Lys-Phe-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(O)=O WLXGMVVHTIUPHE-ULQDDVLXSA-N 0.000 description 3
- JOSAKOKSPXROGQ-BJDJZHNGSA-N Lys-Ser-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JOSAKOKSPXROGQ-BJDJZHNGSA-N 0.000 description 3
- IKXQOBUBZSOWDY-AVGNSLFASA-N Lys-Val-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CCCCN)N IKXQOBUBZSOWDY-AVGNSLFASA-N 0.000 description 3
- JCMMNFZUKMMECJ-DCAQKATOSA-N Met-Lys-Asn Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O JCMMNFZUKMMECJ-DCAQKATOSA-N 0.000 description 3
- XOFDBXYPKZUAAM-GUBZILKMSA-N Met-Met-Ser Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)O)N XOFDBXYPKZUAAM-GUBZILKMSA-N 0.000 description 3
- MIXPUVSPPOWTCR-FXQIFTODSA-N Met-Ser-Ser Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O MIXPUVSPPOWTCR-FXQIFTODSA-N 0.000 description 3
- KYXDADPHSNFWQX-VEVYYDQMSA-N Met-Thr-Asp Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(O)=O KYXDADPHSNFWQX-VEVYYDQMSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 108010002311 N-glycylglutamic acid Proteins 0.000 description 3
- BKWJQWJPZMUWEG-LFSVMHDDSA-N Phe-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 BKWJQWJPZMUWEG-LFSVMHDDSA-N 0.000 description 3
- SWZKMTDPQXLQRD-XVSYOHENSA-N Phe-Asp-Thr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SWZKMTDPQXLQRD-XVSYOHENSA-N 0.000 description 3
- NPLGQVKZFGJWAI-QWHCGFSZSA-N Phe-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CC2=CC=CC=C2)N)C(=O)O NPLGQVKZFGJWAI-QWHCGFSZSA-N 0.000 description 3
- IWZRODDWOSIXPZ-IRXDYDNUSA-N Phe-Phe-Gly Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)NCC(O)=O)C1=CC=CC=C1 IWZRODDWOSIXPZ-IRXDYDNUSA-N 0.000 description 3
- FTVRVZNYIYWJGB-ACZMJKKPSA-N Ser-Asp-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O FTVRVZNYIYWJGB-ACZMJKKPSA-N 0.000 description 3
- FPCGZYMRFFIYIH-CIUDSAMLSA-N Ser-Lys-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O FPCGZYMRFFIYIH-CIUDSAMLSA-N 0.000 description 3
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 3
- VFEHSAJCWWHDBH-RHYQMDGZSA-N Thr-Arg-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O VFEHSAJCWWHDBH-RHYQMDGZSA-N 0.000 description 3
- UDQBCBUXAQIZAK-GLLZPBPUSA-N Thr-Glu-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O UDQBCBUXAQIZAK-GLLZPBPUSA-N 0.000 description 3
- XPNSAQMEAVSQRD-FBCQKBJTSA-N Thr-Gly-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)NCC(=O)NCC(O)=O XPNSAQMEAVSQRD-FBCQKBJTSA-N 0.000 description 3
- SPVHQURZJCUDQC-VOAKCMCISA-N Thr-Lys-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O SPVHQURZJCUDQC-VOAKCMCISA-N 0.000 description 3
- DEGCBBCMYWNJNA-RHYQMDGZSA-N Thr-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)[C@@H](C)O DEGCBBCMYWNJNA-RHYQMDGZSA-N 0.000 description 3
- BDENGIGFTNYZSJ-RCWTZXSCSA-N Thr-Pro-Met Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(O)=O BDENGIGFTNYZSJ-RCWTZXSCSA-N 0.000 description 3
- VBMOVTMNHWPZJR-SUSMZKCASA-N Thr-Thr-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O VBMOVTMNHWPZJR-SUSMZKCASA-N 0.000 description 3
- BONYBFXWMXBAND-GQGQLFGLSA-N Trp-Ile-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N BONYBFXWMXBAND-GQGQLFGLSA-N 0.000 description 3
- LNYOXPDEIZJDEI-NHCYSSNCSA-N Val-Asn-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C(C)C)N LNYOXPDEIZJDEI-NHCYSSNCSA-N 0.000 description 3
- PVPAOIGJYHVWBT-KKHAAJSZSA-N Val-Asn-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C(C)C)N)O PVPAOIGJYHVWBT-KKHAAJSZSA-N 0.000 description 3
- HZYOWMGWKKRMBZ-BYULHYEWSA-N Val-Asp-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N HZYOWMGWKKRMBZ-BYULHYEWSA-N 0.000 description 3
- QHDXUYOYTPWCSK-RCOVLWMOSA-N Val-Asp-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)O)N QHDXUYOYTPWCSK-RCOVLWMOSA-N 0.000 description 3
- DJEVQCWNMQOABE-RCOVLWMOSA-N Val-Gly-Asp Chemical compound CC(C)[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O)N DJEVQCWNMQOABE-RCOVLWMOSA-N 0.000 description 3
- YTUABZMPYKCWCQ-XQQFMLRXSA-N Val-His-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@@H]2C(=O)O)N YTUABZMPYKCWCQ-XQQFMLRXSA-N 0.000 description 3
- JAIZPWVHPQRYOU-ZJDVBMNYSA-N Val-Thr-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](C(C)C)N)O JAIZPWVHPQRYOU-ZJDVBMNYSA-N 0.000 description 3
- JXWGBRRVTRAZQA-ULQDDVLXSA-N Val-Tyr-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](C(C)C)N JXWGBRRVTRAZQA-ULQDDVLXSA-N 0.000 description 3
- DFQZDQPLWBSFEJ-LSJOCFKGSA-N Val-Val-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)O)N DFQZDQPLWBSFEJ-LSJOCFKGSA-N 0.000 description 3
- 108010044940 alanylglutamine Proteins 0.000 description 3
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 3
- 150000001413 amino acids Chemical group 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 108010043240 arginyl-leucyl-glycine Proteins 0.000 description 3
- 108010062796 arginyllysine Proteins 0.000 description 3
- 108010093581 aspartyl-proline Proteins 0.000 description 3
- 108010038633 aspartylglutamate Proteins 0.000 description 3
- 108010092854 aspartyllysine Proteins 0.000 description 3
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 3
- 208000012839 conversion disease Diseases 0.000 description 3
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 3
- 108010027668 glycyl-alanyl-valine Proteins 0.000 description 3
- 108010089804 glycyl-threonine Proteins 0.000 description 3
- 239000005457 ice water Substances 0.000 description 3
- 238000009776 industrial production Methods 0.000 description 3
- 108010044056 leucyl-phenylalanine Proteins 0.000 description 3
- 108010025153 lysyl-alanyl-alanine Proteins 0.000 description 3
- 108010038320 lysylphenylalanine Proteins 0.000 description 3
- 108010005942 methionylglycine Proteins 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 108010084525 phenylalanyl-phenylalanyl-glycine Proteins 0.000 description 3
- 108010084572 phenylalanyl-valine Proteins 0.000 description 3
- 239000008055 phosphate buffer solution Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000006722 reduction reaction Methods 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- OTVAEFIXJLOWRX-NXEZZACHSA-N thiamphenicol Chemical compound CS(=O)(=O)C1=CC=C([C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl)C=C1 OTVAEFIXJLOWRX-NXEZZACHSA-N 0.000 description 3
- 229960003053 thiamphenicol Drugs 0.000 description 3
- 108010061238 threonyl-glycine Proteins 0.000 description 3
- IBIDRSSEHFLGSD-UHFFFAOYSA-N valinyl-arginine Natural products CC(C)C(N)C(=O)NC(C(O)=O)CCCN=C(N)N IBIDRSSEHFLGSD-UHFFFAOYSA-N 0.000 description 3
- NCXTYSVDWLAQGZ-ZKWXMUAHSA-N Asn-Ser-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O NCXTYSVDWLAQGZ-ZKWXMUAHSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- MBOAPAXLTUSMQI-JHEQGTHGSA-N Gly-Glu-Thr Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MBOAPAXLTUSMQI-JHEQGTHGSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- AIOWVDNPESPXRB-YTWAJWBKSA-N Pro-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2)O AIOWVDNPESPXRB-YTWAJWBKSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 229910000365 copper sulfate Inorganic materials 0.000 description 2
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 239000012065 filter cake Substances 0.000 description 2
- HKMLRUAPIDAGIE-UHFFFAOYSA-N methyl 2,2-dichloroacetate Chemical compound COC(=O)C(Cl)Cl HKMLRUAPIDAGIE-UHFFFAOYSA-N 0.000 description 2
- BNTFCVMJHBNJAR-UHFFFAOYSA-N n,n-diethyl-1,1,2,3,3,3-hexafluoropropan-1-amine Chemical compound CCN(CC)C(F)(F)C(F)C(F)(F)F BNTFCVMJHBNJAR-UHFFFAOYSA-N 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 108010029020 prolylglycine Proteins 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000002351 wastewater Substances 0.000 description 2
- LUECCFBGAJOLOX-UHFFFAOYSA-N (4-methylsulfonylphenyl)methanol Chemical compound CS(=O)(=O)C1=CC=C(CO)C=C1 LUECCFBGAJOLOX-UHFFFAOYSA-N 0.000 description 1
- IMSODMZESSGVBE-UHFFFAOYSA-N 2-Oxazoline Chemical compound C1CN=CO1 IMSODMZESSGVBE-UHFFFAOYSA-N 0.000 description 1
- PSVPUHBSBYJSMQ-UHFFFAOYSA-N 4-methylsulfonylbenzaldehyde Chemical compound CS(=O)(=O)C1=CC=C(C=O)C=C1 PSVPUHBSBYJSMQ-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000272517 Anseriformes Species 0.000 description 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- BEQGFMIBZFNROK-JGVFFNPUSA-N Gly-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)CN)C(=O)O BEQGFMIBZFNROK-JGVFFNPUSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- MEQLGHAMAUPOSJ-DCAQKATOSA-N Lys-Ser-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O MEQLGHAMAUPOSJ-DCAQKATOSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- FDMCIBSQRKFSTJ-RHYQMDGZSA-N Pro-Thr-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O FDMCIBSQRKFSTJ-RHYQMDGZSA-N 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 238000011914 asymmetric synthesis Methods 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 125000004267 aziridin-2-yl group Chemical group [H]N1C([H])([H])C1([H])* 0.000 description 1
- 238000010364 biochemical engineering Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- SMWQTDMSXSQXOI-VXGBXAGGSA-N n-[(1r,2s)-3-fluoro-1-hydroxy-1-(4-methylsulfonylphenyl)propan-2-yl]acetamide Chemical compound CC(=O)N[C@H](CF)[C@H](O)C1=CC=C(S(C)(=O)=O)C=C1 SMWQTDMSXSQXOI-VXGBXAGGSA-N 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/02—Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
本发明公开了一种制备氟苯尼考的方法，其特征在于，以式Ⅰ化合物为原料，加入酮还原酶，在酮还原酶催化还原酮羰基的同时动态动力学拆分得到式Ⅱ化合物，再将式Ⅱ化合物的三元环进行开环氟化和可选的进行去保护、二氯乙酰化反应制得氟苯尼考。
Description
技术领域
本发明属于生物制药和生物化工技术领域，具体涉及一种氟苯尼考的制备方法。
背景技术
氟苯尼考又称氟甲砜霉素是一种动物专用的广谱抗生素，主要用于牛、猪、鸡鸭、鱼等动物的细菌性疾病。氟苯尼考结构与甲砜霉素相似，但抗菌活性是甲砜霉素的10倍之多；并且抗菌广谱性及不良反应方面明显优于甲砜霉素。目前氟苯尼考已经成为动物类的主要抗菌药物。鉴于其优良的药效，其应用前景非常广阔。因此氟苯尼考的合成一直受到很大的重视。
氟苯尼考，其结构式如下所示：
目前工业制备氟苯尼考主要是以对甲砜基苯甲醛、甘氨酸等为起始原料，通过缩合、酯化、拆分等步骤制备(2S,3R)-对甲砜基苯丝氨酸乙酯(D-乙酯)。再在D-乙酯为原料的基础上，通过还原、与苄腈反应制备噁唑啉、Ishikawa试剂作用下氟化、水解以及二氯乙酰化等步骤生产，其合成线路如下所示：
目前的氟苯尼考的工业化生产路线必须使用到关键中间体D-乙酯，而生产D-乙酯需要硫酸铜络合制备氨基酸铜盐以及手性拆分等步骤，生产过程中产生大量的硫酸铜废水，并且手性拆分过程浪费了50％的原料，此方法不仅对环境危害大，成本也比较高。另外此工艺在D-乙酯的还原步骤会产生大量的含硼盐废水，处理比较困难，环境负担比较大。在氟化反应步骤需要使用当量的Ishikawa试剂，这类试剂氟原子利用率比较低，成本比较高，对设备的腐蚀性也比较大。综上所述，现有的氟苯尼考生产路线存在生产成本高、环境污染严重等缺陷，因此寻找更合适的工业化生产路线是很有价值的。
鉴于此，化学工作者发展了一些不对称合成氟苯尼考的方法。最近有专利报道了利用对[氮丙啶-2-基][4-(甲砜基)苯基]甲酮进行还原得到的相应的醇中间体，再利用氮丙啶三元环在酸性环境容易开环的性质合成氟苯尼考。比如：
中国专利(公开号CN102827042A)报道了利用手性配体-金属钌催化剂催化氢化制备氮丙啶-2-基][4-(甲砜基)苯基]甲醇，再通过三元环开环制备氟苯尼考。反应过程如下所示：
该方法，利用不对称催化还原避免了手性拆分，原子经济性较高。但是此方法存在催化剂价格昂贵、需要特殊的高压设备反应器等缺点，导致此方法很难实现工业化。
中国专利(公开号CN103936638A)报道了从手性[氮丙啶-2-基][4-(甲砜基)苯基]甲酮出发，通过选择性还原、醇的构型反转、三元环开环等步骤制备氟苯尼考，反应过程如下所示：
该方法，手性原料价格昂贵，反应步骤多，生产成本较高导致此方法工业化价值不大。
中国专利(公开号CN 106316898 A)报道了从手性[氮丙啶-2-基][4-(甲砜基)苯基]甲酮出发，通过在低温条件下利用大位阻还原剂还原得到所需构型的中间体醇、再经过三元环开环、脱保护、二氯乙酰化等步骤制备氟苯尼考，反应过程如下所示：
该方法，手性原料、大位阻的还原剂价格都比较昂贵，反应过程需要低温进行，生产成本较高导致此方法工业化价值不大。
发明内容
本发明针对现有技术的不足，提供了一种简单易行的合成氟苯尼考的新方法，该方法操作简单，条件温和，大幅度降低了生产的成本，适合大规模的工业化生产。
本发明的公开了一种制备氟苯尼考的方法，其特征在于，以式Ⅰ化合物为原料，
加入酮还原酶，在酮还原酶催化还原酮羰基的同时动态动力学拆分得到式Ⅱ化合物式Ⅰ、式Ⅱ中，R为保护基，
再将式Ⅱ化合物的三元环进行开环氟化和可选的进行去保护、二氯乙酰化反应制得氟苯尼考。
优选的，所述R为乙酰基、苄基或-COCHCl2；
优选的，所述开环氟化的步骤通过加入三乙胺氢氟酸盐完成；
优选的，所述酶反应过程中，添加辅酶烟酰胺腺嘌呤双核苷酸作为再生体系；
优选的，添加葡萄糖和葡萄糖脱氢酶实现辅酶烟酰胺腺嘌呤双核苷酸的再生；
优选的，添加异丙醇和可选的添加醇脱氢酶实现辅酶烟酰胺腺嘌呤双核苷酸的再生。
本发明的反应过程如下：
其中，酮还原-动态拆分过程如下：
优选的，当保护基R为COCHCl2时，只需要两步反应即可完成，反应过程如下：
具体实施方式
下面结合具体实施例对本发明做进一步详细的说明，但本发明并不限于以下实施例。
实施例1-5中，R＝乙酰基，反应路线如下：
实施例1：合成化合物(R)-[(R)-1-乙酰基氮丙啶-2-基][4-(甲砜基)苯基]甲醇
在500mL反应瓶中加入0.05M的磷酸缓冲液(pH＝7.5)240g，在搅拌下加入26.7g1-乙酰基-2-(4-甲砜基苯基)甲酰基氮丙啶，20克异丙醇。控制体系温度至35℃，搅拌均匀，在搅拌下依次加入60mg烟酰胺腺嘌呤双核苷酸、1.4g酮还原酶酶粉(购自苏州引航生物科技有限公司，商品编号为YH2068)。开始搅拌反应，20小时后取样HPLC检测，转化率98％以上，反应结束。体系中加入240mL乙酸乙酯，搅拌1小时，过滤(硅藻土助滤除酶)。滤液分层取有机层，水层用乙酸乙酯萃取(3×100mL)，合并有机相，干燥脱溶得到粗品24.8g。收率93％，ee>99％，de 96％产品无需纯化直接用于下一步反应。
实施例2：合成化合物(R)-[(R)-1-乙酰基氮丙啶-2-基][4-(甲砜基)苯基]甲醇
1-乙酰基-2-(4-甲砜基苯基)甲酰基氮丙啶26.7g、葡萄糖20g置于500mL的三口烧瓶，加入270mL pH＝7.5，0.05M的磷酸缓冲液。将三口烧瓶放入反应锅中，设置转速850rpm,温度35℃。然后分别加入60mg烟酰胺腺嘌呤双核苷酸,1.5g葡萄糖脱氢酶(采购自苏州引航生物科技有限公司：商品编号YH1901，或其他已知的葡萄糖脱氢酶)、以及1.5g酮还原酶粉(采购自苏州引航生物科技有限公司：商品编号YH2068)。开始反应，反应过程中用2M的NaOH溶液将pH维持在7.5左右，HPLC监测反应。24小时后反应转化率>98％。反应完毕，反应体系中加入240mL乙酸乙酯，搅拌1小时，过滤(硅藻土助滤除酶)。滤液分层取有机层，水层用乙酸乙酯萃取(3×100mL)，合并有机相，干燥脱溶得到粗品25.2g。收率94.3％，ee>99％，de98％产品无需纯化直接用于下一步反应。
实施例1-2所述YH2068酮还原酶，具有SEQ ID NO.1所示氨基酸序列，其核苷酸序列为SEQ ID NO.2。
实施例3：合成(1R,2S)-3-氟-1-[4-(甲砜基)苯基]-2-乙酰氨基-1-丙醇
将26.9g(R)-[(R)-1-乙酰基氮丙啶-2-基][4-(甲砜基)苯基]甲醇溶解在300ml氯仿中置于500mL的三口烧瓶中，称取30克无水三乙胺氢氟酸盐加入溶液中，加热回流24小时，HPLC监测反应，反应完全后体系降至室温。反应体系中加入200克冰水，用碳酸氢钠调节PH＝8-9,分液，取氯仿层，水相用氯仿萃取(2×100mL)，合并有机相，干燥脱溶得到粗品。粗品用乙醇重结晶得到产品23.4克。
实施例4：合成氟苯尼考氨基物
将28.9g(1R,2S)-3-氟-1-[4-(甲砜基)苯基]-2-乙酰氨基-1-丙醇甲醇溶解在300mL甲醇与100mL 2M KOH的混合溶液中，反应体系加热回流24小时，HPLC监测反应。待反应完全后甲醇蒸去，用二氯甲烷萃取，取有机层，合并有机相，干燥脱溶得到粗品。粗品结晶得到21.2g产品。
实施例5：合成氟苯尼考
在装有搅拌器、回流冷凝器、温度计的100mL三颈瓶中，加入氟苯尼考氨基物24.5g，甲醇100mL和二氯乙酸甲酯20mL。在60-65℃搅拌反应过夜，随后加入活性炭2.5g，保温脱色30min，趁热过滤，向滤液中滴加蒸馏水至有少量结晶析出时停止加水，稍停片刻，继续加入剩余蒸馏水(共350mL)。冷至室温，放置30min，抽滤，滤饼用蒸馏水洗涤，抽干，即得氟苯尼考31g。
实施例6-10中，R＝苄基，反应路线如下：
实施例6：合成化合物(R)-[(R)-1-苄基氮丙啶-2-基][4-(甲砜基)苯基]甲醇
在500mL反应瓶中加入0.05M的磷酸缓冲液(pH＝7.5)300g，在搅拌下加入31.5g1-苄基-2-(4-甲砜基苯基)甲酰基氮丙啶，30克异丙醇。控制体系温度至35℃，搅拌均匀，在搅拌下依次加入63mg烟酰胺腺嘌呤双核苷酸、1.6g酮还原酶酶粉(购自苏州引航生物科技有限公司，商品编号为YH2077)。开始搅拌反应，20小时后取样HPLC检测，转化率97％以上，反应结束。体系中加入300mL乙酸乙酯，搅拌1小时，过滤(硅藻土助滤除酶)。滤液分层取有机层，水层用乙酸乙酯萃取(3×100mL)，合并有机相，干燥脱溶得到粗品29g。收率92％，ee>99％，de 94％产品无需纯化直接用于下一步反应。
实施例7：合成化合物(R)-[(R)-1-苄基氮丙啶-2-基][4-(甲砜基)苯基]甲醇
1-苄基-2-(4-甲砜基苯基)甲酰基氮丙啶31.5g、葡萄糖20g置于500mL的三口烧瓶，加入320mL pH＝7.5，0.05M的磷酸缓冲液。将三口烧瓶放入反应锅中，设置转速850rpm,温度35℃。然后分别加入63mg烟酰胺腺嘌呤双核苷酸,1.6g葡萄糖脱氢酶(采购自苏州引航生物科技有限公司：商品编号YH1901，或其他已知的葡萄糖脱氢酶)、以及1.6g酮还原酶粉(采购自苏州引航生物科技有限公司：商品编号YH2077)。开始反应，反应过程中用2M的NaOH溶液将pH维持在7.5左右，HPLC监测反应。24小时后反应转化率>98％。反应完毕，反应体系中加入300mL乙酸乙酯，搅拌1小时，过滤(硅藻土助滤除酶)。滤液分层取有机层，水层用乙酸乙酯萃取(3×100mL)，合并有机相，干燥脱溶得到粗品28.2g。收率88.9％，ee>99％，de95％产品无需纯化直接用于下一步反应。
实施例6-7所述YH2077酮还原酶，具有SEQ ID NO.3所示氨基酸序列，其核苷酸序列为SEQ ID NO.4。
实施例8：合成(1R,2S)-3-氟-1-[4-(甲砜基)苯基]-2-苄氨基-1-丙醇
将31.7g(R)-[(R)-1-苄基氮丙啶-2-基][4-(甲砜基)苯基]甲醇溶解在300ml氯仿中置于500mL的三口烧瓶中，称取30克无水三乙胺氢氟酸盐加入溶液中，加热回流24小时，HPLC监测反应，反应完全后将至室温。反应体系中加入200克冰水，用碳酸氢钠调节PH＝8-9,分液，取氯仿层，水相用氯仿萃取(2×100mL)，合并有机相，干燥脱溶得到粗品。粗品用乙醇重结晶得到产品24.9克。
实施例9：合成氟苯尼考氨基物
将33.7g(1R,2S)-3-氟-1-[4-(甲砜基)苯基]-2-苄氨基-1-丙醇甲醇溶解在300mL甲醇，体系中加入3.5g 5％的湿Pd/C，常压通入氢气，常温反应5小时，HPLC监测反应。反应完全后，干燥脱溶得到粗品25g。
实施例10：合成氟苯尼考
在装有搅拌器、回流冷凝器、温度计的100mL三颈瓶中，加入氟苯尼考氨基物粗品25g，甲醇100mL和二氯乙酸甲酯20mL。在60-65℃搅拌反应过夜，随后加入活性炭2.5g，保温脱色30min，趁热过滤，向滤液中滴加蒸馏水至有少量结晶析出时停止加水，稍停片刻，继续加入剩余蒸馏水(共350mL)。冷至室温，放置30min，抽滤，滤饼用蒸馏水洗涤，抽干，即得氟苯尼考29g。
实施例11-13中，R＝COCHCl2，反应路线如下：
实施例11：合成化合物(R)-[(R)-1-二氯乙酰基氮丙啶-2-基][4-(甲砜基)苯基]甲醇
在500mL反应瓶中加入0.05M的磷酸缓冲液(pH＝7.5)300mL，在搅拌下加入33.6g1-二氯乙酰基-2-(4-甲砜基苯基)甲酰基氮丙啶，30克异丙醇。控制体系温度至35℃，搅拌均匀，在搅拌下依次加入68mg烟酰胺腺嘌呤双核苷酸、1.7g酮还原酶酶粉(购自苏州引航生物科技有限公司，商品编号为YH2045)。开始搅拌反应，20小时后取样HPLC检测，转化率99％以上，反应结束。体系中加入300mL乙酸乙酯，搅拌1小时，过滤(硅藻土助滤除酶)。滤液分层取有机层，水层用乙酸乙酯萃取(3×100mL)，合并有机相，干燥脱溶得到粗品31.9g。收率95％，ee>99％，de 98％产品无需纯化直接用于下一步反应。
实施例12：合成化合物(R)-[(R)-1-二氯乙酰基氮丙啶-2-基][4-(甲砜基)苯基]甲醇
二氯乙酰基-2-(4-甲砜基苯基)甲酰基氮丙啶33.6g、葡萄糖20g置于500mL的三口烧瓶，加入340mL pH＝7.5，0.05M的磷酸缓冲液。将三口烧瓶放入反应锅中，设置转速850rpm,温度35℃。然后分别加入68mg烟酰胺腺嘌呤双核苷酸,1.7g葡萄糖脱氢酶(采购自苏州引航生物科技有限公司：商品编号YH1901，或其他已知的葡萄糖脱氢酶)、以及1.7g酮还原酶粉(采购自苏州引航生物科技有限公司：商品编号YH2045)。开始反应，反应过程中用2M的NaOH溶液将pH维持在7.5左右，HPLC监测反应。24小时后反应转化率>98％。反应完毕，反应体系中加入300mL乙酸乙酯，搅拌1小时，过滤(硅藻土助滤除酶)。滤液分层取有机层，水层用乙酸乙酯萃取(3×100mL)，合并有机相，干燥脱溶得到粗品31.5g。收率94％，ee>99％，de 98％产品无需纯化直接用于下一步反应。
实施例11-12所述YH2045酮还原酶，具有SEQ ID NO.5所示氨基酸序列，其核苷酸序列为SEQ ID NO.6。
实施例13：合成氟苯尼考
将33.8g(R)-[(R)-1-二氯乙酰基氮丙啶-2-基][4-(甲砜基)苯基]甲醇溶解在350ml氯仿中置于500mL的三口烧瓶中，称取30克无水三乙胺氢氟酸盐加入溶液中，加热回流24小时，HPLC监测反应，反应完全后降至室温。反应体系中加入200克冰水，用碳酸氢钠调节PH＝8-9,分液，取氯仿层，水相用氯仿萃取(2×100mL)，合并有机相，干燥脱溶得到粗品。粗品用甲醇-水重结晶得到产品氟苯尼考28.9克。
实施例14：重组酮还原酶摇瓶表达
上述酮还原酶基因序列通过普通的分子克隆手段构建到pET30a表达质粒中。重组质粒被转化至大肠杆菌BL21(DE3)细胞中得到重组菌。接种单克隆至含有50μg/mL卡那霉素的LB培养基(蛋白胨10g/L，酵母粉5g/L，NaCl 10g/L，pH7.0)中，37度培养过夜。过夜培养物转接至TB培养基(蛋白胨12g/L，酵母提取物24g/L，甘油4mL/L，磷酸二氢钾2.31g/L，磷酸氢二钾12.54g/L)，37度培养至OD600到0.6-0.8，加入终浓度为0.4mM的IPTG，30度诱导表达过夜。离心收集细胞后重悬于20mM pH7.0的磷酸缓冲液，超声破碎细胞，离心，取上清做反应或冻存于-20度以下。
上述实施例只为说明本发明的技术构思及特点，其目的在于让熟悉此项技术的人士能够了解本发明的内容并据以实施，并不能以此限制本发明的保护范围。凡根据本发明精神实质所作的等效变化或修饰，都应涵盖在本发明的保护范围之内。
序列表
<110> 苏州引航生物科技有限公司
<120> 一种制备氟苯尼考的方法
<130> 1
<160> 6
<170> SIPOSequenceListing 1.0
<210> 1
<211> 252
<212> PRT
<213> 人工序列()
<400> 1
Met Thr Asp Arg Leu Lys Gly Lys Val Ala Ile Val Thr Gly Gly Thr
1 5 10 15
Leu Gly Ile Gly Leu Ala Ile Ala Asp Lys Phe Val Glu Glu Gly Ala
20 25 30
Lys Val Val Ile Thr Gly Arg His Ala Asp Val Gly Glu Lys Ala Ala
35 40 45
Lys Ser Ile Gly Gly Thr Asp Val Ile Arg Phe Val Gln His Asp Ala
50 55 60
Ser Asp Glu Ala Gly Trp Thr Lys Leu Phe Asp Thr Thr Glu Glu Ala
65 70 75 80
Phe Gly Pro Val Thr Thr Val Val Asn Asn Ala Gly Ile Ala Val Ser
85 90 95
Lys Ser Val Glu Asp Thr Thr Thr Glu Glu Trp Arg Lys Leu Leu Ser
100 105 110
Val Asn Leu Asp Gly Val Phe Phe Gly Thr Arg Leu Gly Ile Gln Arg
115 120 125
Met Lys Asn Lys Gly Leu Gly Ala Ser Ile Ile Asn Met Ser Ser Ile
130 135 140
Glu Gly Phe Val Gly Asp Pro Thr Leu Gly Ala Tyr Asn Ala Ser Lys
145 150 155 160
Gly Ala Val Arg Ile Met Ser Lys Ser Ala Ala Leu Asp Cys Ala Leu
165 170 175
Lys Asp Tyr Asp Val Arg Val Asn Thr Val His Pro Gly Tyr Ile Lys
180 185 190
Thr Pro Leu Val Asp Asp Leu Glu Gly Ala Glu Glu Met Met Ser Gln
195 200 205
Arg Thr Lys Thr Pro Met Gly His Ile Gly Glu Pro Asn Asp Ile Ala
210 215 220
Trp Ile Cys Val Tyr Leu Ala Ser Asp Glu Ser Lys Phe Ala Thr Gly
225 230 235 240
Ala Glu Phe Val Val Asp Gly Gly Tyr Thr Ala Gln
245 250
<210> 2
<211> 759
<212> DNA
<213> 人工序列()
<400> 2
atgactgatc gtttaaaagg caaagtagca attgtaactg gcggtacctt gggaattggc 60
ttggcaatcg ctgataagtt tgttgaagaa ggcgcaaagg ttgttattac cggccgtcac 120
gctgatgtag gtgaaaaagc tgccaaatca atcggcggca cagacgttat ccgttttgtc 180
caacacgatg cttctgatga agccggctgg actaagttgt ttgatacgac tgaagaagca 240
tttggcccag ttaccacggt tgtcaacaat gccggaattg cggtcagcaa gagtgttgaa 300
gataccacaa ctgaagaatg gcgcaagctg ctctcagtta acttggatgg tgtcttcttc 360
ggtacccgtc ttggaatcca acgtatgaag aataaaggac tcggagcatc aatcatcaat 420
atgtcatcta tcgaaggttt tgttggtgat ccaactctgg gtgcatacaa cgcttcaaaa 480
ggtgctgtca gaattatgtc taaatcagct gccttggatt gcgctttgaa ggactacgat 540
gttcgggtta acactgttca tccaggttat atcaagacac cattggttga cgatcttgaa 600
ggggcagaag aaatgatgtc acagcggacc aagacaccaa tgggtcatat cggtgaacct 660
aacgatatcg cttggatctg tgtttacctg gcatctgacg aatctaaatt tgccactggt 720
gcagaattcg ttgtcgatgg tggatacact gctcaataa 759
<210> 3
<211> 252
<212> PRT
<213> 人工序列()
<400> 3
Met Thr Asp Arg Leu Lys Gly Lys Val Ala Ile Val Thr Gly Gly Thr
1 5 10 15
Leu Gly Ile Gly Leu Ala Ile Ala Asp Lys Phe Val Glu Glu Gly Ala
20 25 30
Lys Val Val Ile Thr Gly Arg His Ala Asp Val Gly Glu Lys Ala Ala
35 40 45
Lys Ser Ile Gly Gly Thr Asp Val Ile Arg Phe Val Gln His Asp Ala
50 55 60
Ser Asp Glu Ala Gly Trp Thr Lys Leu Phe Asp Thr Thr Glu Glu Ala
65 70 75 80
Phe Gly Pro Val Thr Thr Val Val Asn Asn Ala Gly Ile Ala Val Ser
85 90 95
Asn Ser Val Glu Asp Thr Thr Thr Glu Glu Trp Arg Lys Leu Leu Ser
100 105 110
Val Asn Leu Asp Gly Val Phe Phe Gly Thr Arg Leu Gly Ile Gln Arg
115 120 125
Met Lys Asn Lys Gly Leu Gly Ala Ser Ile Ile Asn Met Ser Ser Ile
130 135 140
Glu Gly Phe Val Gly Asp Pro Thr Pro Gly Ala Tyr Asn Ala Ser Lys
145 150 155 160
Gly Ala Val Arg Ile Met Ser Lys Ser Ala Ala Leu Asp Cys Ala Leu
165 170 175
Lys Asp Tyr Asp Val Arg Val Asn Thr Val His Pro Gly Tyr Ile Lys
180 185 190
Thr Pro Leu Val Asp Asp Leu Glu Gly Ala Glu Glu Met Met Ser Gln
195 200 205
Arg Thr Lys Thr Pro Met Gly His Ile Gly Glu Thr Asn Asp Ile Ala
210 215 220
Trp Ile Cys Val Tyr Leu Ala Ser Asp Glu Ser Lys Phe Ala Thr Gly
225 230 235 240
Ala Glu Phe Val Val Asp Gly Gly Tyr Thr Ala Gln
245 250
<210> 4
<211> 759
<212> DNA
<213> 人工序列()
<400> 4
atgactgatc gtttaaaagg caaagtagca attgtaactg gcggtacctt gggaattggc 60
ttggcaatcg ctgataagtt tgttgaagaa ggcgcaaagg ttgttattac cggccgtcac 120
gctgatgtag gtgaaaaagc tgccaaatca atcggcggca cagacgttat ccgttttgtc 180
caacacgatg cttctgatga agccggctgg actaagttgt ttgatacgac tgaagaagca 240
tttggcccag ttaccacggt tgtcaacaat gccggaattg cggtcagcaa tagtgttgaa 300
gataccacaa ctgaagaatg gcgcaagctg ctctcagtta acttggatgg tgtcttcttc 360
ggtacccgtc ttggaatcca acgtatgaag aataaaggac tcggagcatc aatcatcaat 420
atgtcatcta tcgaaggttt tgttggtgat ccaactccgg gtgcatacaa cgcttcaaaa 480
ggtgctgtca gaattatgtc taaatcagct gccttggatt gcgctttgaa ggactacgat 540
gttcgggtta acactgttca tccaggttat atcaagacac cattggttga cgatcttgaa 600
ggggcagaag aaatgatgtc acagcggacc aagacaccaa tgggtcatat cggtgaaact 660
aacgatatcg cttggatctg tgtttacctg gcatctgacg aatctaaatt tgccactggt 720
gcagaattcg ttgtcgatgg tggatacact gctcaataa 759
<210> 5
<211> 252
<212> PRT
<213> 人工序列()
<400> 5
Met Thr Asp Arg Leu Lys Gly Lys Val Ala Ile Val Thr Gly Gly Thr
1 5 10 15
Leu Gly Ile Gly Leu Ala Ile Ala Asp Lys Phe Val Glu Glu Gly Ala
20 25 30
Lys Val Val Ile Thr Gly Arg His Ala Asp Val Gly Glu Lys Ala Ala
35 40 45
Lys Ser Ile Gly Gly Thr Asp Val Ile Arg Phe Val Gln His Asp Ala
50 55 60
Ser Asp Glu Ala Gly Trp Thr Lys Leu Phe Asp Thr Thr Glu Glu Ala
65 70 75 80
Phe Gly Pro Val Thr Thr Val Val Asn Asn Ala Gly Ile Ala Val Ser
85 90 95
Asn Ser Val Glu Asp Thr Thr Thr Glu Glu Trp Arg Lys Leu Leu Ser
100 105 110
Val Asn Leu Asp Gly Val Phe Phe Gly Thr Arg Leu Gly Ile Gln Arg
115 120 125
Met Lys Asn Lys Gly Leu Gly Ala Ser Ile Ile Asn Met Ser Ser Ile
130 135 140
Glu Gly Phe Val Gly Asp Pro Thr Pro Gly Ala Tyr Asn Ala Ser Lys
145 150 155 160
Gly Ala Val Arg Ile Met Ser Lys Ser Ala Ala Leu Asp Cys Ala Leu
165 170 175
Lys Asp Tyr Asp Val Arg Val Asn Thr Val His Pro Gly Tyr Ile Lys
180 185 190
Thr Pro Leu Val Asp Asp Leu Glu Gly Ala Glu Glu Met Met Ser Gln
195 200 205
Arg Thr Lys Thr Pro Met Gly His Ile Gly Glu Thr Asn Asp Ile Ala
210 215 220
Trp Ile Cys Val Tyr Leu Ala Ser Asp Glu Ser Lys Phe Ala Thr Gly
225 230 235 240
Ala Glu Phe Val Val Asp Gly Gly Tyr Thr Ala Gln
245 250
<210> 6
<211> 759
<212> DNA
<213> 人工序列()
<400> 6
atgactgatc gtttaaaagg caaagtagca attgtaactg gcggtacctt gggaattggc 60
ttggcaatcg ctgataagtt tgttgaagaa ggcgcaaagg ttgttattac cggccgtcac 120
gctgatgtag gtgaaaaagc tgccaaatca atcggcggca cagacgttat ccgttttgtc 180
caacacgatg cttctgatga agccggctgg actaagttgt ttgatacgac tgaagaagca 240
tttggcccag ttaccacggt tgtcaacaat gccggaattg cggtcagcaa tagtgttgaa 300
gataccacaa ctgaagaatg gcgcaagctg ctctcagtta acttggatgg tgtcttcttc 360
ggtacccgtc ttggaatcca acgtatgaag aataaaggac tcggagcatc aatcatcaat 420
atgtcatcta tcgaaggttt tgttggtgat ccaactccgg gtgcatacaa cgcttcaaaa 480
ggtgctgtca gaattatgtc taaatcagct gccttggatt gcgctttgaa ggactacgat 540
gttcgggtta acactgttca tccaggttat atcaagacac cattggttga cgatcttgaa 600
ggggcagaag aaatgatgtc acagcggacc aagacaccaa tgggtcatat cggtgaaact 660
aacgatatcg cttggatctg tgtttacctg gcatctgacg aatctaaatt tgccactggt 720
gcagaattcg ttgtcgatgg tggatacact gctcaataa 759
Claims (5)
1.一种制备氟苯尼考的方法，其特征在于，以式Ⅰ化合物为原料，加入酮还原酶，在酮还原酶催化还原酮羰基的同时动态动力学拆分得到式Ⅱ化合物，式Ⅰ、式Ⅱ中，R为乙酰基、苄基或-COCHCl2，
当R为-COCHCl2时，将式Ⅱ化合物的三元环进行开环氟化反应制得氟苯尼考，当R不为-COCHCl2时，将式Ⅱ化合物的三元环进行开环氟化反应,再进行去保护、二氯乙酰化反应制得氟苯尼考，所述酮还原酶具有SEQ ID NO.1、3或5所示氨基酸序列。
2.如权利要求1所述的方法，其特征在于，所述开环氟化的步骤通过加入三乙胺氢氟酸盐完成。
3.如权利要求1所述的方法，其特征在于，所述酶反应过程中，添加辅酶烟酰胺腺嘌呤双核苷酸作为再生体系。
4.如权利要求3所述的方法，其特征在于，添加葡萄糖和葡萄糖脱氢酶实现辅酶烟酰胺腺嘌呤双核苷酸的再生。
5.如权利要求3所述的方法，其特征在于，添加异丙醇和添加醇脱氢酶实现辅酶烟酰胺腺嘌呤双核苷酸的再生。
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2019100926879 | 2019-01-30 | ||
| CN201910092687 | 2019-01-30 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN111500652A CN111500652A (zh) | 2020-08-07 |
| CN111500652B true CN111500652B (zh) | 2024-03-26 |
Family
ID=71872570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910387166.6A Active CN111500652B (zh) | 2019-01-30 | 2019-05-10 | 一种制备氟苯尼考的方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111500652B (zh) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114875084B (zh) * | 2021-02-05 | 2023-10-20 | 上海交通大学 | 一种利用酶级联反应合成(1r,2r)-ampp的方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015157927A1 (zh) * | 2014-04-16 | 2015-10-22 | 湖北美天生物科技有限公司 | 氟苯尼考的合成方法 |
| CN106316898A (zh) * | 2016-08-04 | 2017-01-11 | 湖北美天生物科技股份有限公司 | 氟苯尼考的合成方法 |
| CN109207531A (zh) * | 2017-07-03 | 2019-01-15 | 上海医药工业研究院 | 甲砜霉素与氟苯尼考关键中间体的生物制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006287697A1 (en) * | 2005-09-07 | 2007-03-15 | Schering-Plough Pty. Limited | An improved process for preparing oxazolidine protected aminodiol compounds useful as intermediates to Florfenicol |
-
2019
- 2019-05-10 CN CN201910387166.6A patent/CN111500652B/zh active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015157927A1 (zh) * | 2014-04-16 | 2015-10-22 | 湖北美天生物科技有限公司 | 氟苯尼考的合成方法 |
| CN106316898A (zh) * | 2016-08-04 | 2017-01-11 | 湖北美天生物科技股份有限公司 | 氟苯尼考的合成方法 |
| CN109207531A (zh) * | 2017-07-03 | 2019-01-15 | 上海医药工业研究院 | 甲砜霉素与氟苯尼考关键中间体的生物制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN111500652A (zh) | 2020-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109207531B (zh) | 甲砜霉素与氟苯尼考关键中间体的生物制备方法 | |
| CN112813013B (zh) | 一种生产羟基酪醇的重组大肠杆菌及其应用 | |
| CN107099516A (zh) | 7β‑羟基甾醇脱氢酶突变体及其在熊脱氧胆酸合成中的应用 | |
| CN109706191A (zh) | 一种托莫西汀中间体的酶催化合成方法 | |
| JP2023511025A (ja) | オルリスタット中間体の製造における酵素の用途及び製造方法 | |
| CN113528472B (zh) | 一种细胞色素p450 bm3突变体及其在醋酸群勃龙合成中的应用 | |
| CN107400653B (zh) | 一种含α-糖苷酶基因的重组大肠杆菌及其应用 | |
| CN111500652B (zh) | 一种制备氟苯尼考的方法 | |
| CN113429386B (zh) | 一种r-硫辛酸的合成方法 | |
| CN115404249A (zh) | 一种(s)-尼古丁中间体的制备方法及其应用 | |
| CN112852771B (zh) | 酶催化合成手性氨基醇化合物 | |
| CN111154735A (zh) | 一种烯酮还原酶与一种布瓦西坦中间体的制备方法 | |
| CN109679978B (zh) | 一种用于制备l-2-氨基丁酸的重组共表达体系及其应用 | |
| CN116814572A (zh) | 一种羰基还原酶及其突变体及其在制备手性(r)-8-氯-6-羟基辛酸乙酯中的应用 | |
| WO2017022846A1 (ja) | ピタバスタチンカルシウムの製造方法 | |
| CN108424937B (zh) | 一种酶法合成丹参素的方法 | |
| CN113322291A (zh) | 一种手性氨基醇类化合物的合成方法 | |
| CN113604442B (zh) | 马尾藻甾醇合成酶及其制备方法、应用 | |
| CN112645952B (zh) | 一种(r)-(+)-9-(2-羟丙基)腺嘌呤的合成方法 | |
| CN116121216A (zh) | 羰基还原酶和葡萄糖脱氢酶的融合酶、编码基因、工程菌及应用 | |
| CN106544328B (zh) | 一种亚砜还原酶及其应用和制备方法 | |
| CN111662937B (zh) | 一种制备氯霉素的方法 | |
| CN112176007B (zh) | 一种氨基醇手性中间体的制备方法 | |
| CN111808893B (zh) | 一种氨基醇类药物中间体的生物制备新方法 | |
| JP6585839B2 (ja) | 触媒反応によるｌ−アロイソロイシンの形成におけるアミノトランスフェラーゼ及びイソメラーゼの応用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |